Results per page:
10
20
100
vasculitis graves disease
Your Ad Here
vasculitis graves dysease
High prevalence of ANCA in patients with Graves' disease treated .
. Persistent ANCA may be an important risk for development of systemic vasculitis in patients with Graves disease, treated particularly with propylthiouracil. .
eMedicine - Graves Disease : Article by Sai-Ching Jim Yeung, MD .
. with goiter, autoimmune thyroid disease, or with hypocomplementemic vasculitis are at . Care: With the exception of thyroid storm, Graves disease generally is .
Autoimmunity / Scientific Services / Publication of the Month .
. titers. Propylthiouracil has been reported to induce ANCA-associated vasculitis as side effect in few Graves’ disease patients. In .
Antineutrophil cytoplasmic antibody and vasculitis: much more than .
. Among well studied autoimmune conditions, some parallels can be drawn to Graves disease (GD) (see ref. 17 for review). In pauci-immune vasculitis, as in GD .
Propylthiouracil and carbimazole associated-antineutrophil .
. objective Propylthiouracil treatment of Graves' disease has been postulated to provoke antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. .
a
b
c
d
e
f
g
h
i
j
k
l
m
n
o
p
q
r
s
t
u
v
w
x
y
z
Results per page:
10
20
100
Home Page
